What is the price of Bioqual, Inc. (BIOQ)

The price of Bioqual, Inc. (BIOQ) is $32.50

What is the market cap of Bioqual, Inc. (BIOQ)

The market cap of Bioqual, Inc. (BIOQ) is $29.07M

Bioqual, Inc. (BIOQ) Operating Margin

Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerous critical health domains, including investigations into COVID-19, AIDS, influenza, RSV infection, and various flaviviruses such as Zika and Dengue. Furthermore, their work extends to malaria, hepatitis, and oncology. The firm's comprehensive laboratory capabilities further include processing biological samples, producing virus stocks, precisely quantifying infectious viral loads, and conducting assays like virus neutralization and hemagglutination inhibition. They also utilize advanced techniques such as quantitative PCR, ELISA for antigen and antibody detection, flow cytometry, lymphocyte proliferation studies, and various other cell-based analytical methods. Moreover, Bioqual furnishes specialized support for studies employing animal research models. Established in 1981, Bioqual, Inc. maintains its primary operational base in Rockville, Maryland.

Year	Operating Margin	Change
Not enough data for the provided dates.

Year

Operating Margin

Change

Not enough data for the provided dates.

Company	Operating Margin	Operating Margin Difference	Country
Thermo Fisher Scientific Inc. TMO.US	17.69%	-	US
Danaher Corporation DHR.US	20.42%	-	US
WuXi AppTec Co., Ltd. 603259.SS	0.00%	-	CN
Natera, Inc. NTRA.US	-10.70%	-	US
IDEXX Laboratories, Inc. IDXX.US	32.03%	-	US

Company

Operating Margin

Operating Margin Difference

Country